211 related articles for article (PubMed ID: 9183137)
21. Influence of phototherapy treatment duration for seasonal affective disorder: outcome at one vs. two weeks.
Labbate LA; Lafer B; Thibault A; Rosenbaum JF; Sachs GS
Biol Psychiatry; 1995 Dec; 38(11):747-50. PubMed ID: 8580228
[TBL] [Abstract][Full Text] [Related]
22. A controlled trial of levodopa plus carbidopa in the treatment of winter seasonal affective disorder: a test of the dopamine hypothesis.
Oren DA; Moul DE; Schwartz PJ; Wehr TA; Rosenthal NE
J Clin Psychopharmacol; 1994 Jun; 14(3):196-200. PubMed ID: 8027416
[TBL] [Abstract][Full Text] [Related]
23. Can transcranial brain-targeted bright light treatment via ear canals be effective in relieving symptoms in seasonal affective disorder? A pilot study.
Timonen M; Nissilä J; Liettu A; Jokelainen J; Jurvelin H; Aunio A; Räsänen P; Takala T
Med Hypotheses; 2012 Apr; 78(4):511-5. PubMed ID: 22296809
[TBL] [Abstract][Full Text] [Related]
24. Lux vs. wavelength in light treatment of Seasonal Affective Disorder.
Anderson JL; Glod CA; Dai J; Cao Y; Lockley SW
Acta Psychiatr Scand; 2009 Sep; 120(3):203-12. PubMed ID: 19207131
[TBL] [Abstract][Full Text] [Related]
25. [Changes of sleep quality and mood disorders under the influence of phototherapy in patients with seasonal affective disorders SAD].
Ciesielczyk K; Pracka D; Pracki T; Tafil-Klawe M; Ziółkowska-Kochan M
Psychiatr Pol; 2004; 38(6):1105-14. PubMed ID: 15779674
[TBL] [Abstract][Full Text] [Related]
26. [Platelet serotonin transport in the group of outpatients with seasonal affective disorder before and after light treatment, and in remission (in the summer)].
Swiecicki L; Bidziński A; Tonderska A
Psychiatr Pol; 2005; 39(3):459-68. PubMed ID: 16149756
[TBL] [Abstract][Full Text] [Related]
27. Dawn simulation vs. bright light in seasonal affective disorder: Treatment effects and subjective preference.
Danilenko KV; Ivanova IA
J Affect Disord; 2015 Jul; 180():87-9. PubMed ID: 25885065
[TBL] [Abstract][Full Text] [Related]
28. Prediction of outcome of bright light treatment in patients with seasonal affective disorder: Discarding the early response, confirming a higher atypical balance, and uncovering a higher body mass index at baseline as predictors of endpoint outcome.
Dimitrova TD; Reeves GM; Snitker S; Lapidus M; Sleemi AR; Balis TG; Manalai P; Tariq MM; Cabassa JA; Karim NN; Johnson MA; Langenberg P; Rohan KJ; Miller M; Stiller JW; Postolache TT
J Affect Disord; 2017 Nov; 222():126-132. PubMed ID: 28692905
[TBL] [Abstract][Full Text] [Related]
29. Treatment of seasonal affective disorder (SAD) with hypericum extract.
Kasper S
Pharmacopsychiatry; 1997 Sep; 30 Suppl 2():89-93. PubMed ID: 9342767
[TBL] [Abstract][Full Text] [Related]
30. Side effects induced by bright light treatment for seasonal affective disorder.
Labbate LA; Lafer B; Thibault A; Sachs GS
J Clin Psychiatry; 1994 May; 55(5):189-91. PubMed ID: 8071268
[TBL] [Abstract][Full Text] [Related]
31. [Winter depression and phototherapy. The state of the art].
Gysin F; Gysin F; Gross F
Acta Med Port; 1997 Dec; 10(12):887-93. PubMed ID: 9522484
[TBL] [Abstract][Full Text] [Related]
32. Treatment of seasonal affective disorder with duloxetine: an open-label study.
Pjrek E; Willeit M; Praschak-Rieder N; Konstantinidis A; Semlitsch HV; Kasper S; Winkler D
Pharmacopsychiatry; 2008 May; 41(3):100-5. PubMed ID: 18484551
[TBL] [Abstract][Full Text] [Related]
33. Cognitive-behavioral therapy, light therapy, and their combination in treating seasonal affective disorder.
Rohan KJ; Lindsey KT; Roecklein KA; Lacy TJ
J Affect Disord; 2004 Jun; 80(2-3):273-83. PubMed ID: 15207942
[TBL] [Abstract][Full Text] [Related]
34. Bright light therapy and/or imipramine for inpatients with recurrent non-seasonal depression.
Prasko J; Horacek J; Klaschka J; Kosova J; Ondrackova I; Sipek J
Neuro Endocrinol Lett; 2002 Apr; 23(2):109-13. PubMed ID: 12011795
[TBL] [Abstract][Full Text] [Related]
35. [Phototherapy in psychiatry: clinical update and review of indications].
Gross F; Gysin F
Encephale; 1996; 22(2):143-8. PubMed ID: 8706624
[TBL] [Abstract][Full Text] [Related]
36. Desvenlafaxine 50 and 100 mg/d in the treatment of major depressive disorder: an 8-week, phase III, multicenter, randomized, double-blind, placebo-controlled, parallel-group trial and a post hoc pooled analysis of three studies.
Tourian KA; Padmanabhan SK; Groark J; Brisard C; Farrington D
Clin Ther; 2009 Jun; 31 Pt 1():1405-23. PubMed ID: 19698901
[TBL] [Abstract][Full Text] [Related]
37. Bright light augments antidepressant effects of medication and wake therapy.
Loving RT; Kripke DF; Shuchter SR
Depress Anxiety; 2002; 16(1):1-3. PubMed ID: 12203667
[TBL] [Abstract][Full Text] [Related]
38. Effects of light therapy on neuropsychological function and mood in seasonal affective disorder.
Michalon M; Eskes GA; Mate-Kole CC
J Psychiatry Neurosci; 1997 Jan; 22(1):19-28. PubMed ID: 9002389
[TBL] [Abstract][Full Text] [Related]
39. Adjunctive bright light in non-seasonal major depression.
Martiny K
Acta Psychiatr Scand Suppl; 2004; (425):7-28. PubMed ID: 15527426
[TBL] [Abstract][Full Text] [Related]
40. Transcranial bright light treatment via the ear canals in seasonal affective disorder: a randomized, double-blind dose-response study.
Jurvelin H; Takala T; Nissilä J; Timonen M; Rüger M; Jokelainen J; Räsänen P
BMC Psychiatry; 2014 Oct; 14():288. PubMed ID: 25330838
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
